ArticleThe Journal of clinical investigation2015

Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients.

Francesca Pala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.